CBD Hemp Oil for Cancer Patients

  The Stanley brothers are unhappy with the current state of affairs at the company they founded and are bidding for a return to right the company ship. The dramatic fallout in the CBD industry continues to wreak havoc on the once darling sure bet companies comprising the hemp-based market sector. Chief among those organizations experiencing the corporate and fiscal pain of that continued downward spiral is Charlotte's Web Holdings, based in Denver, Colorado. CW's founders, brothers Joel and Jesse Stanley, were riding high as they took their company public on the Toronto Stock Exchange and the OTCQX Venture Market in the United States in September 2018. However, since then, CW's stock price has plummeted from an all-time high of $21.90 on April 1, 2019, to its current value of only $0.2196 (about 22 cents) as of June 12, 2023. That catastrophic collapse in valuation has prompted the brothers to take action. According to multiple news outlets , the Stanley brothers are call...

The team's deal includes a brand activation experience where fans can learn about the benefits of CBD and other hemp-derived products while taking in a game. The Kansas City Royals organization is officially partnering up with a CBD company to promote the potential health benefits of the hemp-derived cannabinoid to its fans and supporters. According to numerous local and national media outlets , the deal between the Missouri-based MLB franchise and Pure Spectrum CBD, a producer of hemp-based cannabidiol products like oils and gummies, was announced this past Tuesday. The agreement makes the Royals the second Major League team to enter a business relationship with a CBD manufacturer, just two months after the Chicago Cubs inked a similar deal with the CBD sparkling beverage brand MYND DRINKS.        Likewise, both new partnerships come on the heels of a league-wide deal signed between MLB and Charlotte's Web Holdings , one of the largest and most well-known CBD comp...

During a recent webinar conducted by officials from the FDA, comments regarding the legal future of CBD indicated that the path forward might be lengthy and arduous.    Since its introduction into the mainstream market for alternative health and wellness offerings, CBD or Cannabidiol has generated equal parts lucrative sales, a loyal consumer base and controversy. Derived from the hemp plant, which Congress delisted from the Controlled Substances List as part of the 2018 Farm Bill , CBD has gone from a fringe elixir and topical treatment for maladies including anxiety, chronic pain, and crippling epilepsy to a multi-billion dollar industry in a matter of five years. That rapid explosion in growth has translated into big business for farmers, manufacturers, and retailers in the hemp industry. According to an analysis conducted by Precedence Research , the global CBD market generated $15.88 billion in revenue in 2022. Furthermore, researchers anticipate that number to excee...

The regulatory agency is testing the waters on potential revised guidelines for the proliferation of chemically derived variants, including Delta-8 THC . A final showdown between the Drug Enforcement Agency (DEA) and manufacturers of controversial synthetically derived cannabinoids could be on the horizon. According to numerous media outlets , DEA will soon reveal its new rules clarifying the legality of chemically produced hemp derivatives like the politically toxic delta-8 THC isomer. Earlier this month, during the DEA’s 2023 Supply Chain Conference, the Chief of the agency’s Drug and Chemical Evaluation Section, Terrance Boos, when speaking on the topic of emerging trends, informed attendees that DEA officials have received “multiple petitions” on the issue and are “in the process of modifying our [regulations]” on cannabis constituents based on recommendations from the U.S. Department of Health and Human Services (HHS).   His overall PowerPoint presentation covered a wide array...

With both sides of the Atlantic struggling to grapple with how to regulate the lucrative hemp-derived product, many governing bodies could take the easy way out and designate CBD as a drug. It has been five years since the U.S. Congress passed the 2018 Farm Bill , which delisted hemp from the Controlled Substances List . That simple act created a seismic event in the United States and across the globe. Farmers began to cultivate the plant at an accelerated rate, and innovative entrepreneurs took advantage of hemp's legal status to produce a remarkable number of hemp-derived products. One of those items, a favorite of alternative medicine advocates for decades, is CBD or Cannabidiol . Proponents of CBD extol its use for a wide range of health issues. Unfortunately, there is little empirical scientific proof of its efficacy in treating specific diseases or medical conditions. However, scientists have recently found strong evidence for the use of CBD in helping to combat some of the ...

Citing a rigorous interpretation of European Union (EU) guidelines, Czech health officials are banning the marketing and sale of CBD and other hemp-based products. The continuing assault on hemp and its derivatives has spread to Europe. As first reported by Hemptoday , food safety authorities in the Czech Republic say they are implementing a ban on all items containing hemp-derived cannabinoids, most notably CBD. According to the Czech Ministry of Agriculture, the State Agricultural and Food Inspection Authority (SZPI) is putting together a measure to remove all food and dietary supplements containing hemp-based cannabinoid variants from the market. Those items are sold as oils, capsules, tinctures, gummies and other edible products. In addition, the removal also extends to hemp-based topicals and cosmetics. The Ministry did not provide a timetable for when the ban will go into effect.      Hemp industry advocates and stakeholders view the action as extreme, considering t...